1-3 of 3
Tobias Suter
Close
Sort by
Journal Articles

Tissue-specific differentiation of a circulating CCR9 − pDC-like common dendritic cell precursor

Andreas Schlitzer, Alexander F. Heiseke, Henrik Einwächter, Wolfgang Reindl, Matthias Schiemann, Calin-Petru Manta, Peter See, Jan-Hendrik Niess, Tobias Suter, Florent Ginhoux, Anne B. Krug
Journal: Blood
Blood (2012) 119 (25): 6063–6071.
https://doi.org/10.1182/blood-2012-03-418400
Published: 2012
Includes: Supplemental data
Journal Articles

GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.

Pablo Umana, PhD, Moessner Ekkehard, PhD, Bruenker Peter, PhD, Klingner Gabriele, Puentener Ursula, PhD, Tobias Suter, PhD, Roger Grau, PhD, Carla Schmidt, PhD, Sylvia Herter, PhD, Christian Gerdes, PhD, Adam Nopora, PhD, Monika Patre, PhD, Samuel Moser, PhD, Peter Sondermann, PhD, Luise Wheat, PhD, Martin J.S. Dyer, PhD, Sibrand Poppema, PhD, Sabine Bauer, PhD, Manfred Kubbies, PhD, Pamela Strein, PhD, Georg Fertig, PhD, Thomas Friess, PhD, Karim Dabbagh, PhD, Joe DalPorto, PhD, Christian Klein, PhD
Journal: Blood
Blood (2007) 110 (11): 2348.
https://doi.org/10.1182/blood.V110.11.2348.2348
Published: 2007
Journal Articles

Novel 3 rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction.

Pablo Umana, PhD, Ekkehard Moessner, Ph.D., Peter Bruenker, Ph.D., Gabriele Unsin, MSc., Ursula Puentener, MSc., Tobias Suter, Ph.D., Roger Grau, Ph.D., Carla Schmidt, Ph.D., Christian Gerdes, Ph.D., Adam Nopora, Ph.D., Monika Patre, Ph.D., Samuel Moser, MSc., Peter Sondermann, Ph.D., Luise Wheat, Ph.D., Martin J.S. Dyer, Ph.D., Sibrand Poppema, Ph.D., Sabine Bauer, Ph.D., Pamela Strein, Ph.D., Thomas Friess, Ph.D., Christian Klein, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 229.
https://doi.org/10.1182/blood.V108.11.229.229
Published: 2006